This article has been updated with additional information from Twist Bioscience's earnings call.
NEW YORK (GenomeWeb) – Twist Bioscience reported a 119 percent increase in second quarter fiscal year 2019 revenues after the close of market on Tuesday.
"We had another very strong quarter … driven by strong growth in both synbio and our genomics product line," said Emily Leproust, Twist's cofounder and CEO, during a conference call to discuss the financial results.